Take a seat in the front row and listen as some of the world’s foremost scientists introduce you to innovative medicines and treatments.

Close encounters: Designing drugs that recruit the cell’s own machinery to fight cancer and beyond with Michael Erb, PhD

Some of the most devastating diseases are driven by proteins that cannot be targeted with conventional drugs. Scientists are now discovering ways to control disease by recruiting the cell’s own machinery to tackle this challenge. In this free Front Row lecture, Associate Professor Michael Erb will take the audience inside the cell to explain how his team is developing “proximity” drugs. Erb’s innovation has implications to change how scientists and cells join forces to fight against breast, prostate and blood cancers. Join us to learn how proximity drugs can eliminate proteins, rewire essential cellular pathways, and enable researchers to target previously “undruggable” proteins.

About Scripps Research

Committed to unraveling the intricacies of the human body and translating our discoveries into tangible global impact, Scripps Research is consistently ranked among the most influential non-profit research institutes in the world. Throughout our 100-year history, our scientists have expanded the boundaries of scientific understanding and played a pivotal role in the development of 18 FDA-approved medicines that have impacted the lives of countless individuals worldwide.

The Front Row lecture series, now in its ninth season, offers an exclusive glimpse into groundbreaking scientific discoveries in action. Many of these breakthroughs are the result of years of tireless work—made possible by the support of our community.

As we enter another century of science changing life at Scripps Research, our focus remains the same: fueling world-class fundamental and translational research to accelerate the development of medical advances for the benefit of human health.